FMED vs. RSPH
Compare and contrast key facts about Fidelity Disruptive Medicine ETF (FMED) and Invesco S&P 500 Equal Weight Health Care ETF (RSPH).
FMED and RSPH are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. FMED is an actively managed fund by Fidelity. It was launched on Apr 16, 2020. RSPH is a passively managed fund by Invesco that tracks the performance of the S&P 500 Equal Weighted / Health Care -SEC. It was launched on Nov 1, 2006.
Performance
FMED vs. RSPH - Performance Comparison
Loading graphics...
FMED vs. RSPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | -9.18% | 9.69% | 2.29% | -4.20% |
RSPH Invesco S&P 500 Equal Weight Health Care ETF | -5.02% | 9.52% | -0.94% | 3.53% |
Returns By Period
In the year-to-date period, FMED achieves a -9.18% return, which is significantly lower than RSPH's -5.02% return.
FMED
- 1D
- 4.31%
- 1M
- -6.27%
- YTD
- -9.18%
- 6M
- -1.52%
- 1Y
- 4.05%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
RSPH
- 1D
- 1.85%
- 1M
- -9.05%
- YTD
- -5.02%
- 6M
- 3.10%
- 1Y
- 2.26%
- 3Y*
- 1.88%
- 5Y*
- 3.11%
- 10Y*
- 8.17%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FMED vs. RSPH - Expense Ratio Comparison
FMED has a 0.50% expense ratio, which is higher than RSPH's 0.40% expense ratio.
Return for Risk
FMED vs. RSPH — Risk / Return Rank
FMED
RSPH
FMED vs. RSPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Disruptive Medicine ETF (FMED) and Invesco S&P 500 Equal Weight Health Care ETF (RSPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FMED | RSPH | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.19 | 0.12 | +0.07 |
Sortino ratioReturn per unit of downside risk | 0.43 | 0.30 | +0.13 |
Omega ratioGain probability vs. loss probability | 1.05 | 1.04 | +0.01 |
Calmar ratioReturn relative to maximum drawdown | 0.16 | 0.27 | -0.11 |
Martin ratioReturn relative to average drawdown | 0.48 | 0.77 | -0.28 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FMED | RSPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.19 | 0.12 | +0.07 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.19 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.46 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.05 | 0.58 | -0.62 |
Correlation
The correlation between FMED and RSPH is 0.73, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
FMED vs. RSPH - Dividend Comparison
FMED has not paid dividends to shareholders, while RSPH's dividend yield for the trailing twelve months is around 0.74%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RSPH Invesco S&P 500 Equal Weight Health Care ETF | 0.74% | 0.70% | 0.71% | 0.66% | 0.64% | 0.50% | 0.51% | 0.54% | 0.53% | 0.47% | 0.48% | 0.49% |
Drawdowns
FMED vs. RSPH - Drawdown Comparison
The maximum FMED drawdown since its inception was -21.84%, smaller than the maximum RSPH drawdown of -40.49%. Use the drawdown chart below to compare losses from any high point for FMED and RSPH.
Loading graphics...
Drawdown Indicators
| FMED | RSPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -21.84% | -40.49% | +18.65% |
Max Drawdown (1Y)Largest decline over 1 year | -18.33% | -10.87% | -7.46% |
Max Drawdown (5Y)Largest decline over 5 years | — | -21.95% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -30.44% | — |
Current DrawdownCurrent decline from peak | -14.81% | -9.05% | -5.76% |
Average DrawdownAverage peak-to-trough decline | -6.64% | -6.13% | -0.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.90% | 3.77% | +2.13% |
Volatility
FMED vs. RSPH - Volatility Comparison
Fidelity Disruptive Medicine ETF (FMED) has a higher volatility of 8.24% compared to Invesco S&P 500 Equal Weight Health Care ETF (RSPH) at 5.56%. This indicates that FMED's price experiences larger fluctuations and is considered to be riskier than RSPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FMED | RSPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.24% | 5.56% | +2.68% |
Volatility (6M)Calculated over the trailing 6-month period | 13.98% | 10.78% | +3.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.35% | 19.06% | +2.29% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.31% | 16.18% | +2.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.31% | 17.73% | +0.58% |